Matsuda Yukiko, Morino Hiroyuki, Miyamoto Ryosuke, Kurashige Takashi, Kume Kodai, Mizuno Noriyoshi, Kanaya Yuhei, Tada Yui, Ohsawa Ryosuke, Yokota Kazunori, Shimozawa Nobuyuki, Maruyama Hirofumi, Kawakami Hideshi
Department of Epidemiology (Y.M., H. Morino, K.K., Y.K., Y.T., R.O., H.K.), Research Institute for Radiation Biology and Medicine, Hiroshima University; Japan Society for the Promotion of Science (Y.M.), Tokyo; the Department of Clinical Neuroscience (R.M.), Institute for Biomedical Science, Tokushima University; the Department of Neurology (T.K.), National Hospital Organization Kure Medical Center and Chugoku Cancer Center; the Department of Periodontal Medicine (N.M.), Graduate School of Biomedical and Sciences, Hiroshima University; the Department of Plastic Surgery (K.Y.), Hiroshima University Hospital; the Division of Genomics Research (N.S.), Life Science Research Center, Gifu University; the Department of Clinical Neuroscience and Therapeutics (H. Maruyama), Hiroshima University, Japan.
Neurol Genet. 2020 Jan 16;6(1):e396. doi: 10.1212/NXG.0000000000000396. eCollection 2020 Feb.
To determine the genetic underpinnings of slowly progressive spinocerebellar ataxia, autosomal recessive (SCAR), we performed exome analysis and examined the relationship between clinical severity and functional change induced by the mutation.
Homozygosity fingerprinting and exome sequencing were performed to identify causative mutations in 2 consanguineous families. We assessed the expression of D-bifunctional protein (DBP) and the amount of dimerized DBP in fibroblasts by immunoblot and quantitative reverse transcription PCR. The pathogenicity of the mutation was evaluated using the Combined Annotation-Dependent Depletion (CADD) scores; these results were compared with the scores of previously reported mutations.
We identified a homozygous mutation as causative of middle age-onset SCAR: p.Ala175Thr, which is located in that encodes peroxisomal DBP. The patients developed cerebellar ataxia, and the subsequent progression was slow. The symptoms presented were milder than those in previously reported cases. The messenger RNA expression levels were normal, but protein levels were diminished. Dimerization of DBP was also reduced. The CADD score of the identified mutation was lower than those of previously reported mutations.
This is the report of middle age-onset DBP deficiency. Residual functional DBP caused relatively mild symptoms in the affected patients, i.e., slowly progressive ataxia and hearing loss. This study broadens the scope of DBP deficiency phenotypes and indicates that CADD scores may be used to estimate the severity of DBP deficiencies.
为了确定常染色体隐性遗传的缓慢进展性脊髓小脑共济失调(SCAR)的遗传基础,我们进行了外显子组分析,并研究了临床严重程度与突变引起的功能变化之间的关系。
对两个近亲家庭进行纯合性指纹分析和外显子组测序,以鉴定致病突变。我们通过免疫印迹和定量逆转录PCR评估成纤维细胞中D-双功能蛋白(DBP)的表达和二聚化DBP的量。使用联合注释依赖缺失(CADD)评分评估突变的致病性;将这些结果与先前报道的突变评分进行比较。
我们鉴定出一个纯合突变是中年发病的SCAR的病因:p.Ala175Thr,该突变位于编码过氧化物酶体DBP的区域。患者出现小脑共济失调,随后进展缓慢。所表现出的症状比先前报道的病例要轻。信使核糖核酸表达水平正常,但蛋白质水平降低。DBP的二聚化也减少。所鉴定突变的CADD评分低于先前报道的突变。
这是关于中年发病的DBP缺乏症的报告。残留的功能性DBP在受影响的患者中引起相对较轻的症状,即缓慢进展的共济失调和听力丧失。本研究拓宽了DBP缺乏症表型的范围,并表明CADD评分可用于估计DBP缺乏症的严重程度。